Chemiluminescent Labeling and Detection in Gels

Information

  • Research Project
  • 6444421
  • ApplicationId
    6444421
  • Core Project Number
    R43GM064927
  • Full Project Number
    1R43GM064927-01
  • Serial Number
    64927
  • FOA Number
  • Sub Project Id
  • Project Start Date
    4/1/2002 - 22 years ago
  • Project End Date
    9/30/2002 - 22 years ago
  • Program Officer Name
    SWAIN, AMY L
  • Budget Start Date
    4/1/2002 - 22 years ago
  • Budget End Date
    9/30/2002 - 22 years ago
  • Fiscal Year
    2002
  • Support Year
    1
  • Suffix
  • Award Notice Date
    3/18/2002 - 22 years ago
Organizations

Chemiluminescent Labeling and Detection in Gels

The objective of Phase I is to prepare a new family of chemiluminescent label compounds which can be conjugated to proteins and nucleic acids, subjected to electrophoresis and triggered to generate chemiluminescence in the gel. Successful development of the labeling compounds will permit the development of simple methods for direct detection in gels by eliminating membrane transfer and immunological binding protocols used in many techniques. The patented chemiluminescent technology involves reaction of the compounds with inexpensive chemical reagents. A prototypical compound produces visible chemiluminescence within an electrophoresis gel when conjugated to a protein. Additional chemiluminescent compounds emitting at distinct wavelengths spanning the visible spectrum will be synthesized and tested. Synthetic methods for conjugation will be established. Linkers for coupling to amine and thiol groups and a phosphoramidite linker are targeted. The chemiluminescence intensity, kinetics and spectrum of the chemiluminescent compounds will be evaluated. A key feature of the chemiluminescent reaction is that light is emitted as a 1-2 second burst when triggered in solution so that light intensity will be as high as possible when triggering is conducted within a gel. Detection sensitivity in solution and gel matrices will then be assessed using labeled analytes in model assays. PROPOSED COMMERCIAL APPLICATION: The proposed research seeks to develop a family of chemiluminescent direct labels which will enable the rapid and sensitive separation and detection of labeled protein and nucleic acid analytes within electrophoresis gels. The new method would greatly simplify analyses which now rely on membrane transfer or immunological binding protocols. Envisioned uses include preparing labeled polypeptide and nucleic acid size markers, 2D protein analysis, electrophoretic mobility shift analysis of transcriptional factors, nucleic acid hybridization assays and analysis of gene expression levels.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    100000
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    821
  • Ed Inst. Type
  • Funding ICs
    NIGMS:100000\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    LUMIGEN, INC.
  • Organization Department
  • Organization DUNS
    193979002
  • Organization City
    SOUTHFIELD
  • Organization State
    MI
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    480344302
  • Organization District
    UNITED STATES